Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post-Authorisation Safety Study

Journals Menu

Follow SCIRP

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.org/journal/ijcm
E-mail: ijcm@scirp.org

"Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post-Authorisation Safety Study"
written by Saud Alsifri, Abdulrahman M. Almaghamsi, Ashraf S. Mahfouz, Walid Shehab-Eldin, Sameh Rakha,
published by International Journal of Clinical Medicine, Vol.14 No.3, 2023

has been cited by the following article(s):

No relevant information.

Follow SCIRP